...
首页> 外文期刊>Channels >Involvement of intracellular transport in TREK-1c current run-up in 293T cells
【24h】

Involvement of intracellular transport in TREK-1c current run-up in 293T cells

机译:293T细胞中TREK-1c电流增加中细胞内转运的参与

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The TREK-1 channel, the TWIK-1-related potassium (K~(+)) channel, is a member of a family of 2-pore-domain K~(+) (K2P) channels, through which background or leak K~(+) currents occur. An interesting feature of the TREK-1 channel is the run-up of current: i.e. the current through TREK-1 channels spontaneously increases within several minutes of the formation of the whole-cell configuration. To investigate whether intracellular transport is involved in the run-up, we established 293T cell lines stably expressing the TREK-1c channel (K2P2.1) and examined the effects of inhibitors of membrane protein transport, N-methylmaleimide (NEM), brefeldin-A, and an endocytosis inhibitor, pitstop2, on the run-up. The results showing that NEM and brefeldin-A inhibited and pitstop2 facilitated the run-up suggest the involvement of intracellular protein transport. Correspondingly, in cells stably expressing the mCherry-TREK-1 fusion protein, NEM decreased and pitstop2 increased the cell surface localization of the fusion protein. Furthermore, the run-up was inhibited by the intracellular application of a peptide of the C-terminal fragment TREK335–360, corresponding to the interaction site with microtubule-associated protein 2 (Mtap2). This peptide also inhibited the co-immunoprecipitation of Mtap2 with anti-mCherry antibody. The extracellular application of an ezrin inhibitor (NSC668394) also suppressed the run-up and surface localization of the fusion protein. The co-application of these inhibitors abolished the TREK-1c current, suggesting that the additive effects of ezrin and Mtap2 enhance the surface expression of TREK-1c channels and the run-up. These findings clearly showed the involvement of intracellular transport in TREK-1c current run-up and its mechanism.
机译:TREK-1通道是与TWIK-1相关的钾(K〜(+))通道,是2孔域K〜(+)(K2P)通道家族的成员,通过该通道,背景或泄漏K 〜(+)电流出现。 TREK-1通道的一个有趣特征是电流的增加:即通过TREK-1通道的电流在形成整个电池配置后的几分钟内自发增加。为了研究细胞内转运是否参与了启动过程,我们建立了稳定表达TREK-1c通道(K2P2.1)的293T细胞系,并研究了膜蛋白转运抑制剂N-甲基马来酰亚胺(NEM),布雷菲德菌素- A和内吞抑制剂pitstop2(在启动时)。结果表明,NEM和布雷菲德菌素A受到抑制,而pitstop2促进了启动,提示细胞内蛋白质转运参与其中。相应地,在稳定表达mCherry-TREK-1融合蛋白的细胞中,NEM降低,而pitstop2增加了融合蛋白在细胞表面的定位。此外,细胞内应用C端片段TREK335-360的肽段抑制了这种加速,该肽段对应于与微管相关蛋白2(Mtap2)的相互作用位点。该肽还抑制了Mtap2与抗mCherry抗体的免疫共沉淀。 ezrin抑制剂(NSC668394)在细胞外的应用也抑制了融合蛋白的启动和表面定位。这些抑制剂的共同应用消除了TREK-1c电流,这表明ezrin和Mtap2的累加作用增强了TREK-1c通道的表面表达和启动。这些发现清楚地表明了TREK-1c当前启动过程中细胞内运输的参与及其机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号